
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical ointment containing minocycline hydrochloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing minocycline are listed in capsule, tablet, foam, powder and injection forms. No finished minocycline product of any kind is listed in ointment form.
Bases for this dose form are usually nonaqueous. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.
Minocycline hydrochloride is a tetracycline-class antibiotic, taken by mouth or applied to the skin, that a pharmacy may compound when a prescriber orders it.
Minocycline is a semisynthetic, second-generation tetracycline antibiotic. It binds to the 30S subunit of bacterial ribosomes and blocks protein building, which stops susceptible bacteria from growing and multiplying. It is more fat-soluble than doxycycline, so it reaches higher levels in the skin and central nervous system (StatPearls). Manufactured products include generic minocycline hydrochloride capsules and tablets, which are labeled for a long list of infections caused by susceptible bacteria and as adjunctive therapy in severe acne, plus extended-release forms, Minocin injection, Arestin periodontal powder and topical foams, each with its own labeled uses. MedlinePlus lists bacterial infections, acne and rosacea among its uses. A prescriber might order minocycline compounded in a strength or form that is not manufactured, such as a topical preparation, or without a particular dye or excipient. Compounded preparations are not FDA-approved and require a prescription.
Minocycline labels carry no boxed warning. Do not use it if you are allergic to any tetracycline. Like other tetracyclines it can harm a fetus, and use during tooth development (late pregnancy and childhood up to age 8) can permanently discolor teeth. Label warnings include severe skin reactions such as DRESS, which has been fatal; raised pressure in the skull (headache, vision changes); liver injury; sun sensitivity; dizziness or lightheadedness; and C. difficile diarrhea, which can occur more than two months after stopping. Antacids containing aluminum, calcium or magnesium, and iron products, reduce absorption; ask your pharmacist how to time doses. It may make hormonal birth control less reliable, may increase the effect of blood thinners, and should not be combined with isotretinoin. LactMed says short-term use while breastfeeding is probably acceptable but advises avoiding prolonged or repeated courses; the label says to choose between nursing and the drug. Talk to your prescriber or pharmacist about side effects.
Minocycline is a bacteriostatic tetracycline that binds the 30S ribosomal subunit; StatPearls also describes anti-inflammatory and immunomodulatory properties and CYP3A4-mediated hydroxylation and N-demethylation. Per the Aurobindo capsule label, peak serum levels occur at 1 to 4 hours, the serum half-life averages about 15.5 hours, food including dairy does not change the extent of absorption, and half-life lengthened in renal dysfunction. Labeled indications (minocycline hydrochloride capsules, ANDA): infections due to susceptible rickettsiae, Mycoplasma, Chlamydia and many gram-negative and gram-positive organisms, alternatives when penicillin is contraindicated, adjunctive therapy in severe acne and intestinal amebiasis, and asymptomatic meningococcal carriers. StatPearls lists bullous dermatoses, neutrophilic diseases, pyoderma gangrenosum, sarcoidosis and rheumatoid arthritis among off-label uses; these are not FDA-approved indications. LiverTox describes an acute hypersensitivity hepatitis within 1 to 3 months and a chronic autoimmune-like hepatitis with long-term use; StatPearls notes an association with drug-induced lupus. Monitor hematopoietic, renal and hepatic function periodically, and creatinine and BUN in renal impairment; it can falsely elevate urinary catecholamines. Minocycline is not a controlled substance. Dosing is per prescriber.
Wash your hands. Apply a thin layer to the affected area and rub in gently as your label directs. Do not cover with a bandage or wrap unless your prescriber tells you to. Keep it out of your eyes. Do not apply to open wounds or broken skin unless told to. Wash your hands after applying.
Ointments are usually nonaqueous, so a USP <795> default beyond-use date of up to 180 days may apply when no other data exist. Store in the closed container at room temperature, away from heat and direct light, keep from freezing, and keep out of reach of children. Discard after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)